Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis – a potential biomarker role for LysoPC

10 Jan 2018

Abstract excerpt

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a lethal lung disease of unknown etiology. Patients present loss of lung function, dyspnea and dry cough. Diagnosis requires compatible radiologic imaging and, in undetermined cases, invasive procedures such as bronchoscopy and surgical lung biopsy. The pathophysiological mechanisms of IPF are not completely understood. Lung injury with abnormal alveolar...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Share to Metabolomics and Mass Spectrometry Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Sphingolipid Metabolism and Signaling

Source

Identifiers

PMID: 29321022
DOI: 10.1186/s12931-018-0714-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis – a potential biomarker role for LysoPCPMID 29321022Read ↗

Integration of clinical phenoms and metabolomics facilitates precision medicine for lung cancer.Semantic proximity Read ↗

Metabolomic profiling reveals distinct metabolic patterns and a potential circulating biomarker in pre-COPDSemantic proximity Read ↗

Distinct Metabolic Signatures Linked to High-Resolution Computed Tomography Radiographic Phenotypes in Stable and Progressive Fibrotic Lung DiseaseSemantic proximity Read ↗

Serum profiles of metabolomic and GDF-15 differentiate idiopathic pulmonary fibrosis from other interstital lung diseases: a preliminary studySemantic proximity Read ↗

Histological and genetic features and therapeutic responses of lung cancers explored via the global analysis of their metabolome profile.Semantic proximity Read ↗

Novel Lipidomes Profile and Clinical Phenotype Identified in Pneumoconiosis PatientsSemantic proximity Read ↗

Fatty Acid Metabolism-related Genes in Bronchoalveolar Lavage Fluid Unveil Prognostic and Immune Infiltration in Idiopathic Pulmonary FibrosisSemantic proximity Read ↗

Serum Proteomics Identifies Biomarkers Associated With the Pathogenesis of Idiopathic Pulmonary FibrosisSemantic proximity Read ↗

Metabolomics in COPD.Semantic proximity Read ↗

Novel lipidomes profile and clinical phenotype identified in pneumoconiosis patients.Semantic proximity Read ↗

Metabolomics and transcriptomics pathway approach reveals outcome-specific perturbations in COPDSemantic proximity Read ↗

Lipidome Alterations Induced by Cystic Fibrosis, CFTR Mutation, and Lung Function.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.